Medicine guide
Altargo
·
- Prescription status not stated
- Skin
- Active substance
- Retapamulin
- Used in
- Skin
- Made by
- Glaxo Group Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Short term treatment of the following superficial skin infections: impetigo; infected small lacerations, abrasions or sutured wounds. See sections 4.4 and 5.1 for important information regarding the clinical activity of retapamulin against different types of Staphylococcus aureus. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Glaxo Group Ltd |
|---|---|
| Active substance | Retapamulin |
| Used in | Skin |
| Classification | D06AX13 · Skin |
| Authorised on | 2007-05-24 |
| Last updated by the regulator | 2019-03-15 |
| EMA product number | EMEA/H/C/000757 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).